Fda Oks New Therapy For Some Hemophilia Patients

TRENTON, N.J. (AP) — U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia.

Sections:  news   u.s.   
Topics:  Texas   McLennan County   Waco   
RELATED ARTICLES
BING NEWS:
  • Intellia opts out of hemophilia pact with Regeneron
    Intellia Therapeutics terminates co-development agreement with Regeneron Pharmaceuticals for hemophilia gene editing therapy, but will continue ...
    03/22/2024 - 5:40 am | View Link
  • The royal disease: what is hemophilia?
    And advances in gene therapy may reduce symptoms those with mild or moderate hemophilia might have. Ongoing trials are testing the use of viruses as vectors, or vehicles, to deliver factor IX genes ...
    03/18/2024 - 3:20 am | View Link
  • New partners to develop universal gene therapy for hemophilia
    ReciBioPharm and GeneVentiv Therapeutics are teaming up to advance the development of GENV-HEM, a gene therapy for all hemophilia patients, including those who have developed inhibitors against their ...
    03/15/2024 - 1:02 am | View Link
  • Coping with Hemophilia: Navigating Life with a Bleeding Disorder
    "The primary treatment for hemophilia is replacement therapy, which involves infusing clotting factors into the bloodstream to help prevent bleeding episodes," states Dr Chakraborty. In addition to ...
    12/20/2023 - 8:42 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News